Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. (RYTM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
rytm · stock forecast · 20 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 20 Wall Street analysts in the past 3 months
Buy
20 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$157
Consensus
$140
+62.7% upside
Low
$125
Median: $143 · Last Close: $86.15
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$140.20
62.7% upside
High Target
$157
82.2%
Low Target
$125
45.1%
Current Price
$86.15
as of today
Based on analyst price targets, the RYTM stock price prediction for the next 12 months ranges from $125 to $157. The consensus RYTM price forecast of $140.20 implies 62.7% upside from the current price of $86.15.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $84.06 | ↓ 2.43% |
1-day model range: $83.55–$84.56. Peak: $84.56 (-2.43%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $132 | +52.9% |
| 2028 | $174 | +101.5% |
| 2029 | $207 | +140.0% |
| 2030 | $230 | +167.4% |
| 2031 | — | +185.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RYTM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-05-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-06 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-20 | B of A Securities | Maintains | Buy→Buy |
| 2026-03-20 | Citigroup | Maintains | Buy→Buy |
| 2026-03-20 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-17 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-17 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Rhythm Pharmaceuticals, Inc. (RYTM) stock. Of the recent 146 rating actions, 7 were upgrades and 5 were downgrades. 20 analysts currently cover RYTM.
Analyst Recommendation Trends
RYTM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$298M
↓ 65.9% YoY
Revenue Next Year
$541M
↑ 81.5% YoY
EPS This Year
$-3.15
EPS Next Year
$-0.74
↓ 76.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast RYTM EPS of $-3.15 for the current fiscal year, based on estimates from 9 analysts. The RYTM revenue forecast is $298M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The RYTM stock forecast is supported by two independent data sources: analyst consensus ratings from 20 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RYTM price target is $140.20 (+62.7% upside), with an analyst consensus of Buy.
The RYTM short-term stock prediction for tomorrow is $84.06 (-2.43%). The RYTM stock price prediction for 2027 estimates an average of $132. The RYTM stock prediction for 2030 projects a range of $215–$246.
Rhythm Pharmaceuticals, Inc. trades on NASDAQ under the ticker RYTM. The RYTM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
RYTM forecast · 8 questionsAccording to 20 Wall Street analysts, the average 12-month RYTM price target is $140.20, with a high forecast of $157.00 and a low of $125.00. The median price target is shown in the chart above when available. This implies +62.7% potential upside from the current price of $86.15.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.